Meishan Hospital of traditional Chinese Medicine
Welcome,         Profile    Billing    Logout  
 26 Trials 
30 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhang, Hong
NCT03431428: Comparison of Short-term Efficacy and Long-term Prognosis for Reduction Surgery and Radical Resection in Almost-cCR Rectal Cancer Patients

Recruiting
3
477
RoW
transanal surgery, Miles surgery, Preoperative chemoradiotherapy
Zhang Rui
Almost-cCR, Surgery, Rectal Cancer
01/20
12/22
CRAD-001-03, NCT05295173: A Study of r-PA Treating Patients With Acute Ischemic Stroke(RAISE)

Completed
3
1412
RoW
Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA
Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital
Acute Ischemic Stroke
06/23
06/23
NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

Completed
3
163
RoW
Lotilaner, TP-03, S-Misoxam, Vehicle Control
LianBio LLC
Blepharitis
09/23
04/24
NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients (3T Stroke-Ⅲ)

Recruiting
3
1630
RoW
Alteplase, rt-PA, Tenecteplase, TNK-tPA
Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd
Acute Ischemic Stroke
11/23
03/24
TaLaR-02, NCT05984485: The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer

Recruiting
3
766
RoW
neoadjuvant chemotherapy plus total mesorectal excision, total mesorectal excision
Sun Yat-sen University
Rectal Cancer
07/28
07/28
NCT05702489: A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults With Uncomplicated Influenza

Recruiting
2/3
210
RoW
ZX-7101A
Nanjing Zenshine Pharmaceuticals
Influenza, Human
12/23
06/24
NCT04398459: The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia

Recruiting
2
18
RoW
Ibrutinib, BTK inhibitor
Institute of Hematology & Blood Diseases Hospital, China
Refractory/Relapsed Autoimmune Hemolytic Anemia
12/24
06/25
NCT05292196: A Phase II Clinical Trial of TQC3721 Suspension for Inhalation

Recruiting
2
460
RoW
TQC3721 suspension for inhalation, TQC3721 suspension placebo for inhalation
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Obstructive Pulmonary Disease (COPD)
01/24
05/24
BID-PERAL, NCT04423367: Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment

Terminated
2
16
RoW
bortezomib/dexamethasone
Institute of Hematology & Blood Diseases Hospital, China
Acquired Pure Red Cell Aplasia
01/24
02/24
NCT05660785: Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia

Recruiting
2
54
RoW
Herombopag, Cyclosporine A
Institute of Hematology & Blood Diseases Hospital, China, Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Non Severe Aplastic Anemia, Untreated
11/24
05/25
NCT04688736: Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.

Recruiting
2
6642
RoW
Placebo, Chlorpheniramine
Institute of Hematology & Blood Diseases Hospital, China
Allergic Transfusion Reaction
12/25
06/26
NCT04481841: Head Yuanshi Dian Therapy in Burning Mouth Syndrome

Recruiting
1
290
RoW
oryzanol + vitamin B2 (riboflavin) + vitamin E, head yuanshi dian therapy
Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Hospital of TCM, Guiyang Hospital of Stomatology
Burning Mouth Syndrome, Oral Mucosa Disease
02/22
05/22
NCT06101316: A Bridging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB06-036 in Healthy Subjects in China

Recruiting
1
12
RoW
CB06-036
Shanghai Zhimeng Biopharma, Inc.
Healthy Volunteers
10/23
12/23
NCT06216041: To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects

Recruiting
1
138
RoW
IMM-H014, Placebo, IMM-H014 ( FE), Placebo ( FE)
Changchun Intellicrown Pharmaceutical Co. LTD
Nonalcoholic Steatohepatitis (NASH)
07/24
12/24
NCT06160895: A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects

Recruiting
1
90
RoW
TQ-A3334 tablets, TQ-A3334 placebo tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Hepatitis B
07/24
12/24
NCT06427681: An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects

Not yet recruiting
1
40
NA
BH006 for injection, Fosaprepitant for injection+Palonosetron hydrochloride injection, EMEND®+PALONOSETRON
Zhuhai Beihai Biotech Co., Ltd
Bioavailability
09/24
12/24
NCT04645810: A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

Recruiting
1
12
US
High-Dose-Rate Brachytherapy
University of Rochester
Prostate Cancer, HDR
05/24
05/24
NCT03806621: Rota China Registry

Completed
N/A
980
RoW
Rotational Atherectomy
Beijing Anzhen Hospital, BSC International Medical Trading (Shanghai) Co., Ltd.
Coronary Artery Disease
12/20
01/22
UltraFuture I, NCT05498740: Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

Recruiting
N/A
200
RoW
Drug eluting Balloon
Zhejiang Zylox Medical Device Co., Ltd.
Peripheral Arterial Disease (PAD)
12/22
12/24
NCT05608980: 0.01% Hypochlorous Acid in the Treatment of Blepharitis

Recruiting
N/A
100
RoW
0.01% hypochlorous acid, 0.01%HOCI, Placebo
Eye & ENT Hospital of Fudan University, ShuGuang Hospital
Blepharitis
12/22
05/23
NCT05685966: Retrospective Study of COVID-19 on Reproductive Function

Recruiting
N/A
400
RoW
no intervention
Jinling Hospital, China
COVID-19
03/23
01/24
NCT04852406: Protocol-based Management and Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy

Recruiting
N/A
526
RoW
Protocol-based management of perioperative antithrombotic therapy, Protocol-based management, Routine management of perioperative antithrombotic therapy, Routine management
Peking University First Hospital
Antithrombotic Therapy, Perioperative Care, Perioperative Outcomes
12/23
01/24
NCT05685992: Novel Coronavirus Infection and Reproductive Function

Recruiting
N/A
400
RoW
no intervention
Jinling Hospital, China
COVID-19 Infection
01/24
01/24
CSILS, NCT04527861: Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Recruiting
N/A
710
RoW
Single-incision Laparoscopic Surgery, SILS, Conventional Laparoscopic Surgery, CLS
Ruijin Hospital, Dongfang Hospital Affiliated to Tongji University, Fudan University, Changhai Hospital, Shengjing Hospital, RenJi Hospital, Liaoning Cancer Hospital & Institute, Zhejiang Provincial People's Hospital, Shandong Provincial Hospital, The General Hospital of Western Theater Command, Shanghai Jiao Tong University School of Medicine
Colorectal Cancer, Colon Cancer, Rectal Cancer
04/24
04/29
SCDB, NCT06422845: Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis

Not yet recruiting
N/A
328
RoW
Dissolve AV Peripheral Scoring Drug-coated Balloon, Scoring Drug-coated Balloon
DK Medical Technology (Suzhou) Co., Ltd.
Arteriovenous Fistula Stenosis
07/27
07/27
TaLaR, NCT02966483: Transanal Versus Laparoscopic Total Mesorectal Excision For Rectal Cancer

Recruiting
N/A
1114
RoW
TaTME, Transanal TME, LpTME, Laparoscopic TME
Sun Yat-sen University, Peking Union Medical College Hospital, The First Hospital of Jilin University, RenJi Hospital, Shengjing Hospital, The Second People's Hospital of Yibin, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, Nanchong Central Hospital, Zunyi Medical College, The First Affiliated Hospital of University of South China, Xinqiao Hospital, Nanfang Hospital of Southern Medical University, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, The Affiliated Hospital of Guangdong Medical College, The Third Xiangya Hospital of Central South University
Rectal Neoplasms Malignant, Surgery
07/25
07/25
mLOWER, NCT02693496: Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research

Recruiting
N/A
10000
RoW
Installation or registration of smartphone application
Chinese Alliance Against Lung Cancer
Solitary Pulmonary Nodule
10/25
10/25
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System

Not yet recruiting
N/A
2150
RoW
Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy
Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Heart Disease
01/26
01/28
FLORA-01, NCT05730595: Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer

Not yet recruiting
N/A
550
RoW
lymph node dissection, Fluorescence-guided laparoscopic surgery, Radical operation for rectal cancer and sigmoid Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Fudan University, Fujian Province Tumor Hospital, Guangdong Provincial People's Hospital, Shengjing Hospital, Affiliated Hospital of Qinghai University, Hebei Medical University Fourth Hospital, The Second Affiliated Hospital of Harbin Medical University, Jiangxi Provincial Cancer Hospital, The First Hospital of Jilin University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Shanxi Province Cancer Hospital, Nanfang Hospital, Southern Medical University, Second People's Hospital of Yunnan Province, Binzhou Medical University, The First Affiliated Hospital of University of Science and Technology of China, First Affiliated Hospital of Chengdu Medical College, The Second People's Hospital of Yibin, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Colorectal Neoplasms, Fluorescence, Lymph Node Excision
12/26
06/27
TESTING-ON, NCT05434325: TESTING -ON Post-Trial ObservatioNal Cohort Study

Recruiting
N/A
366
Canada, RoW
The George Institute, Peking University Institute of Nephrology
IgA Nephropathy, ESRD, Glomerulonephritis, Kidney Diseases
07/27
07/27

Download Options